Product Information
PROPAFENONE HCL ER 325 MG CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5711 per EA under NDC 59651027760. Its NADAC has been published 145 times since Dec 27, 2023.
FDA first approved this application on Feb 21, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
325 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651027760
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROPAFENONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213096FDA Approved
2/21/2023
TE Code
AB
On Market Since
2/21/2023
Pharmacological Classes
Price Statistics
The NADAC for PROPAFENONE HCL ER 325 MG CAP has been published 145 times since Dec 27, 2023, and over the history we have for it it has declined 55.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5711 per EA |
|---|---|
| All-time high | $1.3572 (Feb 14, 2024) |
| All-time low | $0.4264 (Feb 18, 2026) |
| 52-week high | $0.6559 |
| 52-week low | $0.4264 |
| Median price | $0.7614 |
| Average price | $0.7349 |
| Largest weekly change | +84.4% (Mar 20, 2024) |
| Weeks tracked | 145 |
| Tracking since | Dec 27, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Propafenone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPAFENONE HCL ER 325 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL ER 325 MG CAP, manufactured by Aurobindo Pharma Limited, is $0.5711 per EA (NDC 59651027760), effective Sep 30, 2026.
How has the price of PROPAFENONE HCL ER 325 MG CAP changed over time?
Over the history we have for it, the NADAC for PROPAFENONE HCL ER 325 MG CAP has declined 55.6%. It has been tracked across 145 weekly CMS publications since Dec 27, 2023.
What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL ER 325 MG CAP?
Since Dec 27, 2023, the NADAC for PROPAFENONE HCL ER 325 MG CAP has ranged from a low of $0.4264 (Feb 18, 2026) to a high of $1.3572 (Feb 14, 2024), with a median of $0.7614 per EA.
Are there cheaper alternatives to PROPAFENONE HCL ER 325 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PROPAFENONE HCL ER 325 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures PROPAFENONE HCL ER 325 MG CAP?
PROPAFENONE HCL ER 325 MG CAP (NDC 59651027760) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.